R
Richard M. Hoffman
Researcher at Roy J. and Lucille A. Carver College of Medicine
Publications - 210
Citations - 10684
Richard M. Hoffman is an academic researcher from Roy J. and Lucille A. Carver College of Medicine. The author has contributed to research in topics: Prostate cancer & Population. The author has an hindex of 49, co-authored 197 publications receiving 9923 citations. Previous affiliations of Richard M. Hoffman include University of Arizona & University of New Mexico.
Papers
More filters
Journal ArticleDOI
Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
TL;DR: The literature provides strong evidence that staphylococcal carriage prophylaxis using either oral rifampin or mupirocin ointment in the nares or exit site reduces significantly the rate of exit-site infection due to S. aureus.
Journal ArticleDOI
The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma.
Thomas D. Denberg,Fernando J. Kim,Robert C. Flanigan,Diane L. Fairclough,Brenda L. Beaty,John F. Steiner,Richard M. Hoffman +6 more
TL;DR: In this paper, the authors used multivariable logistic regression to model the effects of patient race, social vulnerability, and their interaction on recommendations for radical prostatectomy (RP) versus radiotherapy.
Journal ArticleDOI
Effects of Misattribution in Assigning Cause of Death on Prostate Cancer Mortality Rates
TL;DR: Net misattribution in death certification was higher in 1995 than 1985, suggesting that misattributed explained about half of the observed increase in crude mortality rates.
Journal ArticleDOI
Sources of glucose variability in insulin‐treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES)
Glen H. Murata,William C. Duckworth,Jayendra H. Shah,Christopher S. Wendel,Richard M. Hoffman +4 more
TL;DR: Clinical and behavioural factors associated with glucose variability in type 2 diabetes are identified and a significant barrier to glycaemic control for diabetic patients on insulin is identified.
Journal ArticleDOI
Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study
Timothy J. Daskivich,Kang-Hsien Fan,Tatsuki Koyama,Peter C. Albertsen,Michael Goodman,Ann S. Hamilton,Richard M. Hoffman,Janet L. Stanford,Antoinette M. Stroup,Mark S. Litwin,David F. Penson +10 more
TL;DR: Men aged >60 years with multiple comorbidities have substantial risk of other-cause mortality within 15 years of diagnosis and should consider conservative management for low-risk disease, given its low incidence of cancer-specific mortality.